arXiv Computer Vision By Kiarash Tajbakhsh, Abdelrahman Faqieh, Michael Jopiti, Javier Garcia-Baroja, Philipp Zens, Branislav Zagrapan, Yuri Tolkach, Martin D. Berger, Aurel Perren, Bastian Dislich, Inti Zlobec, Amjad Khan

Lumen: Parameter-Efficient Alignment of Pretrained Vision and Language Encoders for Zero-Shot Computational Pathology

Read the original on arXiv Computer Vision →

Lumen is a pathology vision‑language model that aligns frozen unimodal foundation models (Virchow2 and BioMedBERT) using rank‑4 adapters and projection heads, training only 0.40% of the total parameters on the QUILT‑1M corpus. It achieves the highest mean chance‑corrected balanced accuracy (0.546) across nine zero‑shot patch benchmarks and demonstrates strong performance on lymph‑node metastasis detection, with AUROC scores of 0.964 internally and 0.955 externally. While it ranks third in cross‑modal retrieval, Lumen’s low‑parameter training yields competitive results at both patch and slide levels.

Machine-generated by The Flow from the publisher's headline and feed description — not written or checked by a human. The full article lives at arXiv Computer Vision.

arXiv Computer Vision
Oct 16

Beyond Sparse Captions: Aligning Slide-Level Text and Patch-Level Vision in Pathology

The paper introduces Locked Image Multiple Instance PreTraining (LIMIT), a method that aligns slide‑level pathology reports with patch‑level visual features by freezing a vision encoder and fine‑tuning a text encoder. LIMIT uses report embeddings as cross‑attention queries over bags of patch features, optimizing slide representations via InfoNCE. Applying LIMIT, the authors create CONCH‑Z, which achieves state‑of‑the‑art zero‑shot performance on 22 pathology tasks, outperforming vision‑language encoders trained on curated caption datasets and narrowing the gap with larger slide‑level foundation models.

By Daniel Shao, Dongmin Bang, Luca L. Weishaupt, Sophia J. Wagner, Nic G. Reitsam, Ming Y. Lu, Long P. Le, Richard J. Chen, Faisal Mahmood
arXiv Computer Vision
Oct 9

PathLang: A Language-Centered Benchmark for Vision-Language Models in Computational Pathology

PathLang is a new, language‑centered benchmark for vision‑language models in computational pathology. It keeps the underlying pathology slides, ground‑truth labels, and image‑text evaluation direction constant while systematically varying the diagnostic language used in prompts, reflecting how pathologists actually rephrase diagnoses. The benchmark covers four task families—zero‑shot classification with image‑text alignment, cross‑modal retrieval, paraphrase robustness, and open‑vocabulary diagnosis retrieval—and evaluates nine VLMs across five public datasets spanning four organs.

By Fanqi Cheng, Kuo Gong, Shangke Liu, Beidi Zhao, Junchao Zhu, Zheyu Zhu, Leiyue Zhao, Fengbei Liu, John Cannon, Gang Wang, Zu-hua Gao, Kenji Ikemura, Yihe Yang, Yaohong Wang, Yuankai Huo, Xiaoxiao Li, Mert R. Sabuncu, Ruining Deng
arXiv AI
Aug 11

Simple Token-Efficient Vision-Language Model for Case-level Pathology Synoptic Report Generation

arXiv:2605. 30716v2 Announce Type: replace-cross Abstract: Generating clinically useful pathology reports for pathology cases from whole-slide images (WSIs) is challenging due to gigapixel resolution, long visual-token sequences, and the complexity of case-level reasoning, where a single case may contain multiple WSIs with heterogeneous tissues and ambiguous findings.

By Zhiyuan Yang, Jiahao Cheng, Vincent Quoc-Huy Trinh, Mahdi S. Hosseini
arXiv Computer Vision
Sep 30

HERO: Histology Encoder for Robust Representation in Oncology

HERO (Histology Encoder for Robust Representation in Oncology) is a ViT‑G/14 pathology foundation model trained with DINO and iBOT objectives and refined using high‑resolution Gram anchoring on a 500‑million‑tile corpus from about 575,000 clinical whole‑slide images. It demonstrates superior robustness to center, scanner, and stain variation compared to other state‑of‑the‑art foundation models, while maintaining competitive performance on tile‑level classification, segmentation, and gene‑expression prediction. Across 39 slide‑level clinical tasks, HERO ranks first on average and achieves the best average rank across six benchmark frameworks under an equal‑weighted analysis.

By Zhi Li (Caris Life Sciences, Irving, TX, United States), Eghbal Amidi (Caris Life Sciences, Irving, TX, United States), Yating Cheng (Caris Life Sciences, Irving, TX, United States), Tyson Dawson (Caris Life Sciences, Irving, TX, United States), Gorkem Can Ates (Caris Life Sciences, Irving, TX, United States), Shuzhen Kuang (Caris Life Sciences, Irving, TX, United States), Norsang Lama (Caris Life Sciences, Irving, TX, United States), Md Ashequr Rahman (Caris Life Sciences, Irving, TX, United States), Zhiying Lu (Caris Life Sciences, Irving, TX, United States), Elisabeth K. Kong (Caris Life Sciences, Irving, TX, United States), Milan Radovich (Caris Life Sciences, Irving, TX, United States), David Spetzler (Caris Life Sciences, Irving, TX, United States), Matthew Oberley (Caris Life Sciences, Irving, TX, United States), George W. Sledge (Caris Life Sciences, Irving, TX, United States), Ming Chen (Caris Life Sciences, Irving, TX, United States)